2.80
Schlusskurs vom Vortag:
$2.825
Offen:
$2.78
24-Stunden-Volumen:
3.16M
Relative Volume:
3.44
Marktkapitalisierung:
$131.90M
Einnahmen:
$138.90M
Nettoeinkommen (Verlust:
$-107.15M
KGV:
-1.1097
EPS:
-2.5232
Netto-Cashflow:
$-79.85M
1W Leistung:
-16.91%
1M Leistung:
-16.67%
6M Leistung:
-44.00%
1J Leistung:
-46.97%
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
QTRX
Quanterix Corp
|
2.80 | 133.07M | 138.90M | -107.15M | -79.85M | -2.5232 |
|
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
MSN Money - MSN
Quanterix targets $169M-$174M 2026 revenue while preparing HD-X IVD filing in 2027 - MSN
Quanterix Corporation (NASDAQ:QTRX) Q1 2026 Earnings Call Transcript - Insider Monkey
QTRX Maintained by TD Cowen -- Price Target Lowered to $4.00 - GuruFocus
Q1 2026 Quanterix Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses By Investing.com - Investing.com India
Quanterix Corporation 2026 Q1 Financials: Akoya Acquisition, Revenue Performance & Forward-Looking Statements - Minichart
Quanterix CEO Everett Cunningham Highlights Market Leadership in Earnings Call - HarianBasis.co
Ameriprise Financial (NASDAQ: QTRX) reports 990,224 shares, 2.1% stake - Stock Titan
QTRX Technical Analysis | Trend, Signals & Chart Patterns | QUANTERIX CORP (NASDAQ:QTRX) - ChartMill
Quanterix Q1 Earnings Call Highlights - Yahoo Finance
Quanterix Q1 2026 slides: $85M synergies offset organic decline - Investing.com
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses - Investing.com
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss - ChartMill
Quanterix (NASDAQ: QTRX) grows revenue 20% but books $19.3M impairment - Stock Titan
QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Quanterix (NASDAQ: QTRX) grows Q1 revenue 20% and keeps 2026 outlook - Stock Titan
Quanterix keeps 2026 outlook, eyes FDA decision on Alzheimer’s test - Stock Titan
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Quanterix Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset - Yahoo Finance
Quanterix (QTRX) COO logs RSU conversion and small tax share disposal - Stock Titan
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix schedules after-close Q1 results, 4:30 p.m. ET call - Stock Titan
[ARS] Quanterix Corp SEC Filing - Stock Titan
Quanterix (NASDAQ: QTRX) details 2026 virtual meeting and pay votes - Stock Titan
Quanterix Corp stock (US74876Y1001): Is its ultra-sensitive protein detection tech strong enough to - AD HOC NEWS
QTRX Maintained by Canaccord Genuity -- Price Target Lowered to $4.00 - GuruFocus
Quanterix unveils Content Innovation Engine at AACR 2026 - SelectScience
Wall Street Zen Downgrades Quanterix (NASDAQ:QTRX) to Sell - MarketBeat
Quanterix (QTRX) Launches AidaBREAST Assay for Breast Cancer Pre - GuruFocus
Quanterix (QTRX) COO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Quanterix (NASDAQ: QTRX) CFO nets shares after RSU vesting and tax withholding - Stock Titan
New breast cancer test predicts recurrence risk and radiation benefit - Stock Titan
Michael Francis Miller Net Worth (2026) - GuruFocus
Quanterix (QTRX) to Launch Content Innovation Engine at AACR Ann - GuruFocus
Quanterix to showcase cancer research tools at AACR meeting - Investing.com
New Quanterix platform is built to move cancer biology toward the clinic - Stock Titan
Aberdeen Group plc Trims Stock Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix (NASDAQ:QTRX) Shares Down 5.7%Here's What Happened - MarketBeat
Quanterix (QTRX) Executive Chair receives 6,178-share stock grant - Stock Titan
Quanterix (QTRX) director awarded 4,310 shares for board service - Stock Titan
Quanterix (QTRX) COO gains stock via RSU vesting with tax withholding - Stock Titan
Is Quanterix Corporation (QTRX) Stock Expanding | Price at $3.79, Up 8.91%Quantitative Analysis - newser.com
Quanterix Corp Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
Quanterix Corp (QTRX) Stock Price Quote Today & Current Price Chart - Capital.com
Quanterix Corp (QTRX) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):